Camp4 Therapeutics Corporation
CAMP
$1.55
-$0.04-2.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.16% | -4.72% | -5.07% | -- | -- |
| Total Depreciation and Amortization | -2.20% | -1.55% | 1.07% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.31% | 26.71% | 24.03% | -- | -- |
| Change in Net Operating Assets | -602.69% | -886.77% | -4.81% | -- | -- |
| Cash from Operations | -6.27% | -14.90% | -3.19% | -- | -- |
| Capital Expenditure | 13.69% | -21.76% | 34.96% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 13.69% | -21.76% | 34.96% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 41.63% | -7.23% | -39.66% | -- | -- |
| Issuance of Common Stock | 43,345.45% | 42,028.93% | 41,232.97% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -454.61% | -- | -- | -- | -- |
| Cash from Financing | 5,771.64% | 38,968.83% | 23,707.97% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.99% | 151.68% | 157.62% | -- | -- |